当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析

博济医药

(300404)

  

流通市值:25.54亿  总市值:35.40亿
流通股本:2.76亿   总股本:3.82亿

博济医药(300404)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.45亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益101140.60万元,未分配利润22599.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产148325.77万元,负债47185.17万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入556,148,773.73341,390,828.56167,424,382.67555,832,418.6
营业总成本519,937,507.73318,142,631.73148,329,824.43538,555,406.78
营业利润31,224,117.9919,471,187.4916,614,526.5217,639,042.66
利润总额31,163,247.9219,470,842.516,631,692.0717,629,796.09
净利润45,361,752.1130,885,291.4717,256,705.2427,192,703.38
其他综合收益-369,497.05136,044.61564,543.88667,904.66
综合收益总额44,992,255.0631,021,336.0817,821,249.1227,860,608.04
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计812,494,881.98849,704,092.06826,383,094.63815,183,866.44
非流动资产合计670,762,774.46638,340,593.49624,667,190.16613,743,208.68
资产总计1,483,257,656.441,488,044,685.551,451,050,284.791,428,927,075.12
流动负债合计417,836,611.43395,992,900.07370,629,578.38357,510,366.21
非流动负债合计54,015,071.5696,579,161.1996,485,488.4791,309,532
负债合计471,851,682.99492,572,061.26467,115,066.85448,819,898.21
归属于母公司股东权益合计983,289,679.21970,971,624.65958,936,223.85955,852,728.28
股东权益合计1,011,405,973.45995,472,624.29983,935,217.94980,107,176.91
负债和股东权益合计1,483,257,656.441,488,044,685.551,451,050,284.791,428,927,075.12
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计497,374,990.12334,684,679.52142,260,961.86578,751,926.63
经营活动现金流出小计513,415,087.89329,893,883.48158,025,773.22542,797,785.68
经营活动产生的现金流量净额-16,040,097.774,790,796.04-15,764,811.3635,954,140.95
投资活动现金流入小计519,457,964.76447,270,355.99152,916,907.74895,113,511.29
投资活动现金流出小计706,160,191.88506,802,835.03306,644,423.68928,211,644.73
投资活动产生的现金流量净额-186,702,227.12-59,532,479.04-153,727,515.94-33,098,133.44
筹资活动现金流入小计9,330,897.139,284,327.158,768,600.5150,968,412.31
筹资活动现金流出小计72,068,307.525,317,191.4917,292,543.864,042,408
筹资活动产生的现金流量净额-62,737,410.37-16,032,864.34-8,523,943.386,926,004.31
汇率变动对现金及现金等价物的影响-317,404.61209,425.6756,482.37449,815.68
现金及现金等价物净增加额-265,797,139.87-70,565,121.67-177,959,788.2390,231,827.5
期末现金及现金等价物余额129,359,171.55324,591,189.75217,196,530.25395,156,311.42
最新报告期:2024-08-30
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中原证券李琳琳0.170.230.322024-08-30
TOP↑